Opsy Holding (OPSYH.SL) Stock Price

Opsy Holding Price

CLOSED
9.00
​
Market closed

Over the last 16 years Opsy Holding grew revenue by 60.4% annually, reaching 6.69 M SEK. For Opsy Holding, the net margin of -257.5% is up versus -48,914.3% a few years ago.

Opsy Holding stock price

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Opsy Holding business model & stock analysis

Opsy Holding AB develops a software platform for insurance companies and medical advisors, focusing on anti-metastatic therapies related to the Wnt-5a protein. The company's products target the metastatic process through specific small molecules that interact with Wnt-5a mechanisms. Insurance companies and medical advisors purchase the platform to integrate advanced therapeutic insights into their services. The company's primary market segment consists of healthcare technology providers seeking innovative solutions for metastasis research. Opsy Holding AB's software platform is designed to support medical advisors and insurance firms in evaluating small molecules that specifically interact with the Wnt-5a protein's role in metastasis. The company's focus on Wnt-5a mechanisms positions its products for specialized healthcare applications. Insurance companies use the platform to enhance their risk assessment models with advanced therapeutic data. The company's business model centers on providing a technology platform that bridges medical research and insurance applications. By targeting the Wnt-5a protein's role in metastasis, Opsy Holding AB offers a niche solution for healthcare technology providers. The platform's value lies in its ability to connect specific small molecule evaluations with practical applications in insurance and medical advisory services.

Frequently asked questions about Opsy Holding

Converted at the current exchange rate, the Opsy Holding share trades at 0.82 EUR (9.00 SEK).

The revenue cannot currently be calculated for Opsy Holding.

The profit cannot currently be calculated for Opsy Holding.

The P/E ratio cannot be calculated for Opsy Holding at the moment.

The P/S cannot be calculated for Opsy Holding currently.

The Eulerpool Quality Score for Opsy Holding is 2/10.

The ISIN of Opsy Holding is SE0025399199. The ISIN (International Securities Identification Number) is a globally unique identifier for securities.

The ticker of Opsy Holding is OPSYH.SL. The ticker symbol is used to trade Opsy Holding shares on the stock exchange.

Fair ValueTerminal
8.10 SEK
Over-/UndervaluationTerminal
Fairly valued
Industry
Software
Number of shares
Employees
Revenue per Employee
955,857.14 SEK
Revenue growth Ø5 years
EBIT growth Ø5 years
Net Income growth Ø5 years
Country
Sweden
Currency
SEK
Initial public offering
Dec 17, 2010
ISIN
SE0025399199
Cusip
W6716A104
Market capitalization
114.30 M SEKMicro Cap
52-Week Range
PEG
—
P/E ratio
P/Ee
—
P/Se
—
EV/EBIT
—
P/B Ratio
74.08
ROE (Return on Equity)
ROA (Return on Assets)
ROCE (Return on Capital Employed)
ROIC (Return on Invested Capital)
-755.41 %
Last updated Nov 2, 2026, 11:43 AM

Opsy Holding Peer Group

All fundamentals and in-depth analysis of Opsy Holding

Our stock analysis for Opsy Holding stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Opsy Holding. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.